Ingredient name record

salicylic acid

Korean search label: 살리실릭애씨드

Evidence at a glance

6official function labelsIngredient context 2selected human studiesNot a full review

0selected legal receiptsNot a compliance verdict

Evidence coverage, not an efficacy or safety score.

Identity & coverage details

Official CosIng inventory context recorded; chemical identity and the complete current regulatory profile remain unverified; selected human studies available.

Recorded presence is not a safety rating, recommended dose or benefit claim.

Identity and formulation context

Names are indexed using case and whitespace normalization. Botanical, chemical and marketing identities have not been independently equated.

The cream study combined salicylic acid with chloroxylenol; the other tested a high-strength procedural peel. Neither establishes the independent effect or appropriate use of a cosmetic 2% leave-on product. Betaine Salicylate and related salts are separate identities.

Discovery spellings and aliases

2% bha · beta hydroxy acid · bha · bha 필링 · salicylic acid · 비에이치에이 · 살리실릭 애씨드 · 살리실릭애씨드 · 살리실산

Search-only metadata; an alias is not proof of chemical equivalence.

Functions listed by CosIng

ANTI-SEBORRHEICFRAGRANCEHAIR CONDITIONINGKERATOLYTICPRESERVATIVESKIN CONDITIONING

Inventory functions describe the ingredient entry, not a finished product’s effects.

How this inventory match is used

The European Commission’s CosIng inventory is informational. An entry is not permission to use an ingredient or a safety assessment. Listed functions describe the inventory entry; they do not establish a finished product’s effects. The match uses the exact ingredient name, with case and whitespace normalization.

SALICYLIC ACID · Inventory identifiers

Inventory record: 37595 · Active
CAS identifiers in this entry: 69-72-7
EC identifiers in this entry: 200-712-3
Inventory restriction references: III/98 V/3
References require checking the current legal text; they are not a complete restriction assessment.

Checked 2026-10-02 · Read the official CosIng entry

Human study context

Primary publications checked 2026-10-02. These are selected studies, not a systematic review, safety rating or instructions for using a product.

Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study

2003 · Original abstract reviewed

Material tested: 0.5% chloroxylenol plus 2% salicylic acid cream, compared with 5% benzoyl peroxide gel.
Study design: Randomized, double-blind active-comparator trial.
Participants: 37 volunteers with acne: 18 received the combination cream and 19 the comparison gel.
Concentration and schedule in the study: Study medication applied twice daily to the entire face for 12 weeks.
What the authors reported: Both groups had fewer inflammatory and non-inflammatory lesions; between-group lesion reductions were not significantly different. Erythema and photosensitivity were reported less frequently with the combination at week 12.

What this does not establish

The combination cannot isolate the contribution of salicylic acid.
Small drug-treatment trial with an active comparator, not a cosmetic exfoliant trial.

Read the original publication

Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris

2008 · Original abstract reviewed

Material tested: 30% salicylic acid peel, compared with 30% glycolic acid peel.
Study design: Randomized, double-blind, controlled split-face study.
Participants: 20 patients with mild-to-moderately severe facial acne.
Concentration and schedule in the study: Six study peel sessions spaced two weeks apart; a two-month post-treatment assessment. Peel contact time is absent from the abstract.
What the authors reported: Both peels improved assessed acne, without a significant efficacy difference. The salicylic side retained improvement at follow-up; the glycolic side had more adverse events after the initial session.

What this does not establish

A 30% procedural peel cannot establish effects or a schedule for low-strength cosmetic leave-on products.
Small trial; no vehicle or untreated comparator. Publication was January 2008 after online publication in December 2007.

Read the original publication

Still unverified

This is a selected partial literature record, not a systematic review or a complete scientific profile.
Cosmetic functions and jurisdiction-specific restrictions are not established by these research abstracts.
Study preparations have not been matched to any Treatfolio product, batch, market or concentration.
Chemical identity, the complete current regulatory profile and finished-product effects remain unverified.